Merck Serono Middle East FZ-LLC seeks your permission to communicate with you via email, SMS, phone calls, WhatsApp, social media channels, and other digital channels to keep you updated with relevant non promotional and promotional information. The non-promotional communications are intended to enhance scientific medical education and provide you with multiple sources of data/information and digital tools to better manage chronic diseases, and achieve better outcomes, while the promotional communications are intended to send you updates on our products, services, or events, and generally provide other healthcare news.
 
By signing this consent form, you agree to Merck Serono Middle East FZ-LLC sending you email, SMS, WhatsApp, Social Media messages, and conduct phone calls and use other digital channels
(as you elect below) for the purpose described above. We will process your personal information securely and in accordance with all relevant regulations on data protection and electronic communications, and in line with the IPHA or the ABPI codes of practice.
 
You will be given the options to unsubscribe from any communications, if you have any queries, or you want to opt-out all together from any electronic communications, you can contact Merck’s medical information department at mc.gcc@merckgroup.com. If you want to report an adverse event please send a mail to drug.safety.middleeast@merckgroup.com. In case of adverse event reporting, you agree that Merck Middle East Drug Safety Department may contact you to get more details about the report if needed.